NMDA Receptors

Shop By

22 Items

per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. NMDA antagonist

    Non-opioid analgesic with muscle relaxant properties.
  2. NMDA receptor antagonist

    Memantine hydrochloride is an antagonist at the NMDA receptor, binding to the ion channel site. it was used in the treatment of Parkinsonism.
  3. NMDA receptor antagonist

    Orphenadrine citrate is a NMDA receptor antagonist with Ki of 6.0 +/- 0.7 μM, HERG potassium channel blocker.
  4. Felbamate is an antagonist at the NMDA-associated glycine binding site.
  5. NMDA Receptor Antagonist

    TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
  6. NMDA receptor antagonist

    (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM.
  7. NMDA antagonist

    Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).
  8. NMDA receptor antagonist.

    (-)-MK 801 maleate acts as a potent, selective, and non-competitive NMDA receptor antagonist. It acts by binding to a site located within the NMDA associated ion channel.
  9. NMDA receptor antagonist

    DNQX is a non-N-methyl-D-aspartate (non-NMDA) receptor complex antagonist.
  10. NMDA receptors antagonist

    NVP-AAM077 inhibited progenitor cells proliferation in the subventricular zone and dentate gyrus and reduced the survival of newborn cells in the dentate gyrus in the adult mice.
  11. NMDA/glycine receptor antagonist

    L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor,
  12. AMPA/kainate antagonist

    CNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 uM for AMPA and kainate receptors, respectively, versus IC50 = 25 uM for NMDA receptors).
  13. NMDA receptor antagonist

    Ifenprodil tartrate is the atypical N-methyl-D-aspartate (NMDA) receptor antagonist, inhibits NMDA-induced currents at NR1A/NR2B receptors with high affinity (IC50 = 0.34 μM).
  14. NMDA antagonist

    D-AP5 is a selective N-methyl-D-aspartate (NMDA) receptor antagonist that competitively inhibits the glutamate binding site of NMDA receptors.
  15. NMDA receptor antagonist

    7CKA is a NMDA receptor antagonist that acts at the glycine site.
  16. Muscarinic antagonist

    Procyclidine hydrochloride is a muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in Parkinsonism.
  17. NMDA receptor antagonist

    Mephenesin is an NMDA receptor antagonist, is a centrally acting muscle relaxant.
  18. NMDA antagonist

    AZD-4282, also known as aminoacetic acid and glycine, is a N-methyl-D-aspartate (NMDA) receptor antagonist potentially for the treatment of neuropathic pain.
  19. NMDA receptor antagonist

    Transcrocetinate disodium, extracted from saffron (Crocus sativus L.), acts as an NMDA receptor antagonist with high affinity.
  20. NMDA receptor antagonist

    7-Chlorokynurenic acid sodium salt is a potent and selective antagonist of the glycine B coagonist site of the N-methyl-D-aspartate (NMDA) receptor (IC50=0.56 μM).
  21. NR2C/NR2D-selective NMDA receptor antagonist

    QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC50 values are 3, 6, 229, and >300, >300 μM for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively).
  22. non-NMDA receptor antagonist

    DNQX Disodium is a water-soluble form of selective non-NMDA receptor antagonist DNQX.

22 Items

per page
Set Descending Direction